Argent Biopharma ( (AU:RGT) ) has shared an update.
Argent Biopharma Limited has announced the quotation of 1,388,157 ordinary fully paid securities on the ASX, effective April 23, 2025. This move is part of the company’s strategic efforts to enhance its market presence and provide additional value to its stakeholders by increasing the liquidity of its shares.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative medical therapies. The company is listed on the Australian Securities Exchange (ASX) under the issuer code RGT.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.65M
For a thorough assessment of RGT stock, go to TipRanks’ Stock Analysis page.